NeurAxis, Inc.
General ticker "NRXS" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $30.7M (TTM average)
NeurAxis, Inc. follows the US Stock Market performance with the rate: 42.0%.
Estimated limits based on current volatility of 2.6%: low 7.07$, high 7.45$
Factors to consider:
- Total employees count: 19 as of 2023
- Current price 93.8% above estimated high
- Earnings for 15 months up through Q1 (+1 year) are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.59$, 3.96$]
- 2025-12-31 to 2026-12-31 estimated range: [1.55$, 3.81$]
Short-term NRXS quotes
Long-term NRXS plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $2.68MM | $2.46MM | $2.69MM |
| Operating Expenses | $6.06MM | $9.12MM | $9.84MM |
| Operating Income | $-3.37MM | $-6.66MM | $-7.16MM |
| Non-Operating Income | $-1.41MM | $-7.96MM | $-1.08MM |
| Interest Expense | $0.32MM | $0.48MM | $0.17MM |
| R&D Expense | $0.23MM | $0.17MM | $0.21MM |
| Income(Loss) | $-4.78MM | $-14.63MM | $-8.24MM |
| Profit(Loss)* | $-4.78MM | $-14.63MM | $-8.24MM |
| Stockholders Equity | $-5.57MM | $-1.40MM | $2.07MM |
| Inventory | $0.05MM | $0.02MM | $0.04MM |
| Assets | $1.48MM | $0.51MM | $4.76MM |
| Operating Cash Flow | $-2.30MM | $-6.69MM | $-6.10MM |
| Capital expenditure | $0.06MM | $0.07MM | $0.03MM |
| Investing Cash Flow | $-0.06MM | $-0.07MM | $-0.03MM |
| Financing Cash Flow | $2.29MM | $6.59MM | $9.74MM |
| Earnings Per Share** | $-0.57 | $-2.32 | $-1.19 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.